Innovations in Artificial Intelligence and Genomics Research

  • ID: 4519924
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 3

This edition of the Genetic Technology TOE depicts life sciences trends across genomics. Discovery of genetic risk factors for common complex diseases, an artificial intelligence platform for assembling biological data, advancing precision oncology via whole genome sequencing, and cutting edge adjacent technologies have been profiled. Ongoing clinical trials for whole genome sequencing have also been presented.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 3

Advances in Deep Learning and Precision Genomics

  • Discovering Genetic Risk Factors for Common Complex Diseases
  • Assembling Biological Data to Artificial Intelligence Platform
  • Advancing Precision Oncology via Whole Genome Sequencing
  • Innovating by Introducing Cutting Edge Adjacent Technologies

Clinical Trials and Industry Interactions

  • Ongoing Clinical Trials
  • Industry Interactions
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll